IMPACT OF UGT1A9 AND CYP2B6 POLYMORPHISM ON PHARMACOKINETICS OF PROPOFOL IN KOREAN PATIENTS.

被引：0
|
作者：
Kim, M. [1 ]
Jin, S. [1 ]
Noh, G. [1 ,2 ]
机构：
[1] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Clin Pharmacol & Therapeut, Seoul, South Korea
[2] Asan Med Ctr, Dept Anesthesiol & Pain Med, Seoul, South Korea
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2012年 / 91卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：S115 / S115
页数：1
相关论文
共 50 条
  • [21] CYP2B6 18492T→C Polymorphism Compromises Efavirenz Concentration in Coinfected HIV and Tuberculosis Patients Carrying CYP2B6 Haplotype*1/*1
    Manosuthi, Weerawat
    Sukasem, Chonlaphat
    Thongyen, Supeda
    Nilkamhang, Samruay
    Manosuthi, Sukanya
    Sungkanuparph, Somnuek
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2014, 58 (04) : 2268 - 2273
  • [22] Evaluation of UGT Protein Interactions in Human Hepatocytes: Effect of siRNA Down Regulation of UGT1A9 and UGT2B7 on Propofol Glucuronidation
    Foti, Robert S.
    Konopnicki, Camille M.
    Dickmann, Leslie J.
    Tracy, Jeffrey M.
    Tukey, Robert H.
    Wienkers, Larry C.
    FASEB JOURNAL, 2013, 27
  • [23] Stereoselective glucuronidation and hydroxylation of etodolac by UGT1A9 and CYP2C9 in man
    Tougou, K
    Gotou, H
    Ohno, Y
    Nakamura, A
    XENOBIOTICA, 2004, 34 (05) : 449 - 461
  • [24] Population Differences in the Genetic Polymorphism of CYP2B6 May Impact on the Pharmacology of MMT
    Nurfadhlina, M.
    Nasir, M.
    Darussalam, B.
    Azhar, M. Y. M.
    Tan, S. C.
    Ismail, R.
    PUBLIC HEALTH GENOMICS, 2015, 18 : 12 - 12
  • [25] Involvement of CYP2B6 in the biotransformation of propofol by human liver microsomes
    TANG BingWANG JunkeFENG WanyuDepartment of AnesthesiologyFirst Affiliated HospitalChina Medical UniversityShenyang ChinaDepartment of Clinical Pharmacologythe First Affiliated HospitalChina Medical UniversityShenyang China
    沈阳药科大学学报, 2008, 25(S1) (S1) : 102 - 102
  • [26] Substrate-dependant impact of a novel exon 1 polymorphism in the human UGT1A9 gene
    Guillemette, C
    Villeneuve, L
    DRUG METABOLISM REVIEWS, 2003, 35 : 59 - 59
  • [27] Effects of clopidogrel and the CYP2B6*6 allele on the metabolism and pharmacokinetics of efavirenz in healthy male Korean subjects.
    Jiang, F.
    Desta, Z.
    Kim, H.
    Yeo, C.
    Shon, J.
    Liu, K.
    Lee, S.
    Flockhart, D. A.
    Shin, J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 83 : S19 - S19
  • [28] Pharmacogenetics of CYP2A6, CYP2B6, and UGT2B7 in the Context of HIV Treatments in African Populations
    Ford, Graeme R.
    Niehaus, Antoinette
    Joubert, Fourie
    Pepper, Michael S.
    JOURNAL OF PERSONALIZED MEDICINE, 2022, 12 (12):
  • [29] THE IMPACT OF CYP2B6 GENOTYPE ON EFAVIRENZ AUTO-INDUCTION: PHARMACOKINETICS MODEL AND SIMULATION
    Li, L.
    Desta, Z.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2009, 85 : S55 - S55
  • [30] THE EFFECT OF WOOHWANGCHEONGSIMWON SUSPENSION ON THE PHARMACOKINETICS OF BUPROPION, A SUBSTRATE OF CYP2B6
    Kim, H.
    Park, S.
    Shim, E.
    Kim, H.
    Shon, J.
    Bae, S.
    Liu, K.
    Shin, J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2009, 85 : S53 - S54
12345